translation agency

PR Newswire
Newest Beanie Baby Created in Honor of Ariel Glaser Unveiled to

June 1, 2000
LOS ANGELES, June 1 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation and Ty, Inc. today announced the newest Beanie Baby created in memory of Elizabeth and Paul Glaser's daughter, Ariel who died in 1988 from complications from AIDS. All profits of Ty, Inc. from its sale will be donated to the Foundation. Today, the new Ariel(TM) Beanie Baby, which will be available in retail stores this month, will be given away to all children currently admitted in the Mattel Children's Hospital at UCLA.

"Our heartfelt appreciation goes to Ty Warner and all our friends at Ty, Inc.," said Paul Glaser, chairman of the board, the Elizabeth Glaser Pediatric AIDS Foundation. "The Ariel Beanie Baby will help us raise awareness about the impact of HIV and AIDS on babies, mothers and families around the world, while raising critical funds for pediatric research. Every day, 1,800 children are infected around the world. Clearly, our work is far from over. Ty's extraordinary gift will help us continue our quest to discover a vaccine and cure."

A painting created by Ariel, who spent much time painting and drawing with her father, inspired the Ariel Beanie Baby. At age five, Ariel painted how she envisioned the world -- as a garden of beauty -- filled with sunshine and surrounded by love. Today, her inspiration serves as the foundation's logo representing hope for children everywhere.

"All of us at UCLA are deeply moved by today's extraordinary partnership that will help continue the critical work of the Elizabeth Glaser Pediatric AIDS Foundation," said Dr. Ed McCabe, physician in chief of the Mattel Children's Hospital at UCLA. "We salute the compassion and vision of Ty Warner that will provide us invaluable resources to help us improve the health of children here and around the world."

The Elizabeth Glaser Pediatric AIDS Foundation established its reputation as the leading worldwide non-profit organization dedicated to funding and conducting scientific research for children with HIV/AIDS. When the Pediatric AIDS Foundation was created in 1988, there was no coordinated research of the disease's effect on children and none of the drugs used for treating adults with AIDS were tested or approved for children. Since then, the foundation has raised more than $100 million to help children.

Today, the Elizabeth Glaser Pediatric AIDS Foundation continues to build on its unique model of innovative and collaborative scientific research to advance medical treatments for children. The Foundation works to eliminate mother to child transmission, to accelerate the discovery of new treatments for other serious and life threatening diseases, and to ensure that children are at the forefront of every scientific breakthrough.

SOURCE Elizabeth Glaser Pediatric AIDS Foundation

CONTACT: Carrie Hyun of the Elizabeth Glaser Pediatric AIDS Foundation, 310-314-1459 or 202-427-7888; or Roxanne Moster, Mattel Children's Hospital at UCLA, 310-794-2264/



www.aegis.org